ERA Interim and cross-border injunctions against pharmaceutical patent infringement
Jan-Diederik Lindemans

Interim and cross-border injunctions against pharmaceutical patent infringement

This e-presentation deals with the judicial interpretation of some articles of the Brussels I Regulation in relation to the competent jurisdiction for interim and cross-boarder injunctions in patent litigation cases. The speaker focusses the first part of his speech on the Solvay v Honeywell case (2012) where the CJEU gave some guidelines as to the competent jurisdiction for cross-boarder injunctions in patent infringement cases committed by several defendants. The second part of the speech is dedicated to comments on a national decision (Bayer/Sandoz/Effik Benelux) where the Belgium Court of Appeal gave some guidelines as to the competent jurisdiction for interim injunctions against patent infringers.

Jan-Diederik Lindemans

Information

Standard version

This version of the e-presentation allows you to jump back and forward to the section of most interest.
No certificate can be provided for using this version.

Start

Certified version

This version requires you to view the full e-presentation and to take a short quiz at the end. A certificate can then be issued entitling you to CPD points in selected jurisdictions.

Start